, Tracking Stock Market Picks
Enter Symbol:
Pharmion Corporation (PHRM) [hlAlert]

up 49.60 %

Pharmion Corporation (PHRM) rated Buy

Posted on: Wednesday,  Oct 24, 2007  9:25 AM ET by HSBC Securities

HSBC Securities rated Buy Pharmion Corporation (PHRM) on 10/24/2007, when the stock price was $48.34. Since then,
Pharmion Corporation has gained 49.61% as of 09/25/2008's recent price of $72.32.
If you would have followed this HSBC Securities's recommendation on PHRM, you would have gained 49.6% of your investment in 337 days.

Pharmion Corp is creating a global pharmaceutical company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients.

HSBC has refined and refocused its Global Equities organisation, creating a lean and flexible business model built to meet the needs of global issuers and investors today and in the future. Acknowledging the changing demands of clients, we have also refined our research model, moving away from traditional maintenance to focus on long term, thematic research (a two-year-plus horizon) combined with short term (zero to three months), real-time, actionable ideas both for companies and sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/24/2007 9:25 AM Buy
48.34 60.00
as of 5/23/2009
1 Week   
1 Month   
3 Months   
1 YTD up  15.04 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy